AKTIV-DRY

Basic Information

2100 Central Ave., Suite 109
Boulder, CO, 80301-

Company Profile

n/a

Additional Details

Field Value
DUNS: 136952087
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Thermostable Sublingual Measles Vaccine Dry Wafers

    Amount: $149,998.00

    "Measles is a highly contagious, human disease that is spread by the respiratory route, and, in the developing world, remains a leading cause of death due to vaccine-preventable infectious diseases in ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. A new, rapidly dissolving and thermally stable dry powder Hepatitis-B vaccine

    Amount: $939,918.00

    DESCRIPTION (provided by applicant): The overarching goal of this project is to move a new, dry powder formulation of Hepatitis-B vaccine on its path to commercialization. In the Phase I SBIR we teste ...

    SBIR Phase II 2012 Department of Health and Human Services
  3. Aktiv-Neb: A Dry Powder Inhaler for Anti-RSV siRNA Microparticles

    Amount: $99,990.00

    DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to develop a novel dry powder inhalation system, Aktiv-NebTM, for delivering antiviral drug (siRNAs) p ...

    SBIR Phase I 2008 Department of Health and Human Services
  4. Development of a Micronized Needle-Free Nicotine Vaccine for Smoking Cessation an

    Amount: $823,623.00

    DESCRIPTION (provided by applicant): Aktiv-Dry LLC, in collaboration with Nabi Biopharmaceuticals, proposes to develop and evaluate in animal models the needle-free respiratory delivery of fine dry po ...

    SBIR Phase II 2008 Department of Health and Human Services
  5. Product Formulation and Process Design for Commercial Production of Soluable Phytosterols

    Amount: $296,000.00

    Commercially available products rich in phytosterol may now be used to cut serum low-density lipoprotein by as much as 14 percent. Unfortunately, phytosterols are poorly soluble and therefore present ...

    SBIR Phase II 2006 Department of Agriculture
  6. Development of a Micronized Needle-Free Nicotine Vaccine for Smoking Cessation an

    Amount: $99,989.00

    DESCRIPTION (provided by applicant): Aktiv-Dry LLC, in collaboration with Nabi Biopharmaceuticals, proposes to develop and evaluate in animal models the needle-free respiratory delivery of fine dry po ...

    SBIR Phase I 2006 Department of Health and Human Services
  7. A New Process for Producing Phytosterol and Lycopene Nano- and Micro-Particles

    Amount: $79,985.00

    Phytosterols and lycopene are neutraceuticals that are known antioxidants and cancer inhibitors. Unfortunately, they do not dissolve readily in body fluids and therefore present unique problems concer ...

    SBIR Phase I 2004 Department of Agriculture
  8. Inhalable IgG Synthesis For Influenza Immunoprophylaxis

    Amount: $99,600.00

    DESCRIPTION (provided by applicant): This Phase I SBIR proposal is the first step in the development of inhalable IgG microparticles for immunoprophylaxis against Influenza A, a category C Priority P ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government